Expert Opinion on Investigational Drugs

Therapeutic developments in multiple sclerosis
pp. 655-670(16)
Author: Goodin D.S.

Anti-inflammatory drugs: a hope for Alzheimer’s disease?
pp. 671-683(13)
Authors: Hüll M.; Lieb K.; Fiebich B.L.

Oestrogen and nerve growth factor – neuroprotection and repair in Alzheimer’s disease
pp. 685-694(10)
Author: Granholm A-C.

Neuroprotection in cerebrovascular disease
pp. 695-711(17)
Author: Jain K.K.

Current status of viral gene therapy for brain tumours
pp. 713-726(14)
Author: Gupta N.

Immunotherapeutic approaches to paraneoplastic neurological disorders
pp. 727-733(7)
Author: Blaes F.

Neurokinin receptor antagonists
pp. 735-746(12)
Authors: Leroy V.; Mauser P.; Gao Z.; Peet N.P.

Apoptosis modulators in the therapy of neurodegenerative diseases
pp. 747-764(18)
Authors: Deigner H-P.; Haberkorn U.; Kinscherf R.

Therapeutic potential of positive AMPA receptor modulators in the treatment of neurological disease
pp. 765-777(13)
Author: Yamada K.A.

Mechanisms of action and resistance to tubulin-binding agents
pp. 779-788(10)
Author: Dumontet C.

Immune-adhesion molecules in the prevention of allograft rejection and reperfusion injury
pp. 789-805(17)
Author: Behrend M.

Influence of photodynamic therapy on immunological aspects of disease - an update
pp. 807-817(11)
Authors: Hunt D.W.; Chan A.H.

Ziprasidone: comprehensive overview and clinical use of a novel antipsychotic
pp. 819-828(10)
Authors: Daniel D.G.; Copeland L.F.

An assessment of rufinamide as an anti-epileptic in comparison with other drugs in clinical development
pp. 829-840(12)
Author: Jain K.K.

Zaleplon - a review of a novel sedative hypnotic used in the treatment of insomnia
pp. 841-858(18)
Author: Heydorn W.E.

Nicaraven for the treatment of cerebral vasospasm in subarachnoid haemorrhage
pp. 859-870(12)
Author: Jain K.K.

Remacemide: current status and clinical applications
pp. 871-833(-37)
Authors: Schachter S.C.; Tarsy D.

Pharmacology and clinical experience with repaglinide
pp. 885-898(14)
Authors: Massi-Benedetti M.; Damsbo P.

Ongoing trials in Alzheimer’s disease
pp. 899-915(17)
Authors: Sramek J.J.; Cutler N.R.

Ongoing trials in HIV protease inhibitors
pp. 917-928(12)
Author: Tavel J.A.

Angiogenesis - Research Frontiers. A Basic Science Conference of the New York Academy of Medicine
pp. 929-935(7)
Authors: Sepp-Lorenzino L.; Pan B-S.